Skip to main content
. 2014 May;28(5):243–250. doi: 10.1155/2014/317623
Disease progression Reported progression rates, % (uncertainty interval) Reference(s)
Diuretic-sensitive ascites to diuretic refractory ascites 6.7 (4.0–9.4) 8,2027
Diuretic-sensitive ascites to liver-related death 11.0 (7.7–14.3) 8,2027
Variceal hemorrhage to liver-related death (first year) 40.0 (33.4–46.6) 8,2027
Variceal hemorrhage to liver-related death (subsequent years) 13.0 (8.5–17.5) 8,2027
Hepatic encephalopathy to liver-related death (first year) 68.0 (65.9–70.1) 8,2027
Hepatic encephalopathy to liver-related death (subsequent years) 40.0 (37.8–42.2) 8,2027
Diuretic-refractory ascites to liver-related death 33.0 (28.0–38.0) 8,2027
Hepatocellular carcinoma to liver-related death (first year) 70.7 (43–77.0) 26,58
Hepatocellular carcinoma to liver-related death (subsequent years) 16.2 (11–23.0) 58
Liver transplant to liver-related death (first year) 33.1–10.7 (2.8–0.4) 30,31
Liver transplant to liver-related death (subsequent years) 3.9–4.8 (7.6–1.0) 30,31